| 期刊全稱(chēng) | Advances in Cancer Treatment | | 期刊簡(jiǎn)稱(chēng) | From Systemic Chemot | | 影響因子2023 | Iago Dillion Lima Cavalcanti,José Cleberson Santos | | 視頻video | http://file.papertrans.cn/147/146977/146977.mp4 | | 發(fā)行地址 | Provides comprehensive content on cancer pathophysiology, treatment modalities and antineoplastic chemotherapy in an easy-to-read format.Offers up-to-date information on the target therapies used in c | | 圖書(shū)封面 |  | | 影響因子 | .This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment..We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells.?..The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The p | | Pindex | Book 2021 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-23 20:08
發(fā)表于 2025-3-21 18:12:04
